On March 5th, a group of leaders including Hong Liya, Director of Zhejiang Institute for Food and Drug Control, Chen Bilian, Deputy Director of Zhejiang Institute for Food and Drug Control, Ma Linke, Deputy Director of Zhejiang Institute for Food and Drug Control, and Cheng Qiaoyuan, Director of Cosmetics Institute of Zhejiang Institute for Food and Drug Control, visited Benefit Pharmaceutical for inspection and guidance. Wu Hui, Member of the Standing Committee and Deputy District Mayor of Liandu District, Lishui City, Zhou Jirong, Deputy Director of the Municipal Market Supervision Bureau, and responsible persons of relevant functional departments participated in the research. Wu Lihua, Chairman of Benefit Pharmaceutical, Zhu Meipeng, Production Director, Zhang Shengxian, Quality Director and other management personnel received them and accompanied the inspection throughout the process.

01 Exhibition Hall Visit

Wu Lihua, Chairman of Benefit Pharmaceutical, extended a warm welcome to the leaders from the drug inspection system, expressed sincere gratitude to all leaders for their long-term support for the growth and development of the enterprise, and accompanied them into the Benefit Traditional Chinese Medicine Science and Technology Culture Exhibition Hall, systematically explaining the enterprise's strategic development blueprint, covering historical evolution, core business matrix, vertical integration of industrial chain and layout of the big health industry ecosystem.

02 Symposium and Exchange

At the symposium, Chairman Wu Lihua pointed out that in the face of the aging population trend and the market potential of the silver economy, the company will deepen the "integration of medical care and elderly care" strategic path, and strive to build a diversified product matrix covering edible fungus health products, functional foods and Sanqingshan daily chemical products.

Director Hong Liya highly recognized the brand concept of Benefit Pharmaceutical. She believed that Benefit Pharmaceutical's exploration in the big health future factory project demonstrates Zhejiang Province's spirit of daring to innovate and taking the lead. At the same time, it actively promotes the cooperation between Jinqianliu and Lishui Institute for Food and Drug Control to apply for the revision project of Zhejiang Province's traditional Chinese medicine processing standard system, so as to enhance the industrial application value of authentic medicinal materials and jointly promote the development of Zhejiang's traditional Chinese medicine industry.

03 End of the Research

This research not only deepened the cooperative relationship between Zhejiang Institute for Food and Drug Control and Benefit Pharmaceutical, but also laid a solid foundation for in-depth cooperation between the two sides in the field of big health. In the future, Benefit Pharmaceutical will continue to adhere to the concept of "quality first, speed first, innovation first", actively strengthen basic research, optimize industrial layout, make every effort to promote the modernization of traditional Chinese medicine, and provide industrial paradigm reference for Zhejiang Province to build the strategic goal of "a strong province of traditional Chinese medicine".